ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

174 Episodo

1. Ultimate DAPT Trial Principal Results - Ticagrelor monotherapy following one month of dual antiplatelet therapy (DAPT) outperforms 12-month DAPT (aspirin and ticagrelor) post PCI for reducing clinical

   Publicado: 21/5/2024
2. Be Active RCT: Gamification & Financial Incentives to Increase Physical Activity

   Publicado: 14/5/2024
3. Statin Intolerance, Inclisarin, and the VICTORION-INITIATE Trial

   Publicado: 7/5/2024
4. ARISE-HF Primary Results: Selective Aldose Reductase Inhibitor For Diabetic Cardiomyopathy

   Publicado: 23/4/2024
5. The Future of Cardiology - Value-Based Care, Private Equity and the Practice Landscape

   Publicado: 16/4/2024
6. EMPACT-MI Results: Empagliflozin After Acute Myocardial Infarction

   Publicado: 9/4/2024
7. From JACC: HFpEF: Practical Guidance for Clinicians

   Publicado: 2/4/2024
8. From JACC: Aortic Valve Calcium and the Long-Term Risk of Incident Severe AS

   Publicado: 26/3/2024
9. From JACC: Low-Density Lipoprotein Cholesterol Testing Following MI Hospitalization Among Medicare Beneficiaries

   Publicado: 19/3/2024
10. JACC State-of-the-Art Review: Racial and Ethnic Disparities in Perioperative Health Care Among Patients Undergoing Cardiac Surgery

    Publicado: 12/3/2024
11. From JACC: National Trends in Coronary Artery Disease Imaging: Associations With Health Care Outcomes and Costs

    Publicado: 5/3/2024
12. ACCEL Lite: Top Takeaways from the AFib Guidelines

    Publicado: 29/2/2024
13. ACCEL Lite: From JACC: Return-to-Play for Elite Athletes With Genetic Heart Diseases Predisposing to Sudden Cardiac Death

    Publicado: 27/2/2024
14. AHA Late-Breaker ARTESiA: Apixaban for the Prevention of Stroke in Patients With Subclinical AF

    Publicado: 20/2/2024
15. ACCEL Lite: Behind the ACC 2023 Guideline for Chronic CAD: Conversations and Controversies

    Publicado: 15/2/2024
16. ACCEL Lite: Top Takeaways from the ACC 2023 Guideline for Chronic CAD for the Practicing Clinician

    Publicado: 13/2/2024
17. ACCEL Lite: Management of Worsening Heart Failure with Reduced Ejection Fraction

    Publicado: 6/2/2024
18. ACCEL Lite: AHA Late-Breaker: SELECT – Semaglutide and CV Outcomes in Patients with Overweight or Obesity Who Do Not Have Diabetes

    Publicado: 23/1/2024
19. ACCEL Lite: From JACC: Managing Patients with Moderate Aortic Stenosis

    Publicado: 16/1/2024
20. ACCEL Lite: Top Takeaways from 2023: General Cardiology with Andrew Kates, MD, FACC

    Publicado: 9/1/2024